Trusted by 100,000+ International Patients
Ovarian Cancer Treatment: Spain vs United Arab Emirates
Cost, Quality & Recovery Compared
$20000
Spain Starting Cost
$20000
United Arab Emirates Starting Cost
See how these top medical tourism destinations compare for Ovarian Cancer Treatment.
| Comparison Factor | Spain | United Arab Emirates | Winner |
|---|---|---|---|
| Average Cost (in USD) | 20000 - 40000 | 20000 - 40000 | Both Equal |
| Success Rate (Min and Max) | 65% – 88% | 60% - 85% | Spain |
| Advanced Technology | Advanced gynecologic oncology surgery, robotic and minimally invasive tumor debulking, PET-CT imaging, molecular diagnostics (BRCA/HRD testing), HIPEC therapy, and targeted/immunotherapy programs in specialised cancer centres. | Advanced gynecologic oncology surgery, laparoscopic and robotic tumour debulking, PET-CT imaging, BRCA genetic testing, targeted therapy, and chemotherapy programs in specialised cancer centres. | Both Equal |
| JCI Accredited Hospitals | 15+ | 15+ | Both Equal |
| Visa Process | Schengen Medical Visa / Short-Term Visa | Medical Visa / Tourist Visa | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Spain and United Arab Emirates maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Hospitals in Spain follow strict European Union healthcare standards and are regulated by the Spanish Ministry of Health, with internationally recognised oncology and gynecologic cancer programs.
Outcomes depend on cancer stage, tumour biology, and completeness of cytoreductive surgery. Specialised centres follow ESMO and international oncology treatment guidelines.
Healthcare services are regulated under Spain’s national health system and EU frameworks, ensuring high standards in oncology care, chemotherapy safety, and surgical protocols.
Hospitals in the UAE are accredited by Joint Commission International (JCI) and regulated by MOHAP, DHA, and DOH, ensuring high standards in oncology care and surgical safety.
Outcomes depend on cancer stage and treatment approach; specialised oncology centres follow international protocols such as NCCN and ESMO guidelines.
Healthcare is regulated by the Ministry of Health & Prevention (MOHAP), Dubai Health Authority (DHA), and Department of Health (DOH - Abu Dhabi), ensuring strict oncology treatment protocols and chemotherapy safety standards.
| Quality Metric | Spain | United Arab Emirates |
|---|---|---|
Accredited Hospitals | 15+ | 15+ |
Average Success Rate | Yes | 60–85% |
Post-op Survival (1 Year) | Available | 75–85% |
Top Speciality Hospital Hubs | Barcelona, Madrid, Valencia | Dubai, Abu Dhabi |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Gynecologic oncologists
High-volume
Gynecologic oncologists
Moderate to high Volume
View All Ovarian Cancer Treatment Surgeons in United Arab Emirates →
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Hospitals in Spain are equipped with comprehensive cancer centres including advanced surgical theatres, robotic-assisted surgery systems, and specialised gynecologic oncology departments. Facilities include radiation oncology units, PET-CT imaging, molecular pathology labs, and oncology ICUs to support complex cancer treatments.
Luxury healthcare experience
Hospitals in the UAE have advanced oncology centres with modern surgical theatres, robotic surgery systems, and specialised gynecologic oncology units. Facilities include radiation oncology, high-resolution diagnostic imaging, molecular testing laboratories, and oncology ICUs to support complex cancer surgeries and chemotherapy treatments.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Ovarian Cancer Treatment in both countries.
Treatment may involve surgery followed by chemotherapy, targeted therapy, or HIPEC, depending on the stage.
Patients are monitored closely post-surgery before transitioning to recovery units.
Regular oncology follow-ups are required to track the response to treatment.
Long-term surveillance includes imaging, tumour marker monitoring (CA-125), and periodic oncology consultations.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Patients may undergo surgery followed by chemotherapy or targeted therapy based on cancer stage.
Close monitoring is done immediately after surgery in specialised oncology units
Patients often require multiple chemotherapy cycles after discharge.
Long-term follow-up includes imaging, CA-125 monitoring, and oncology consultations.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Ovarian Cancer Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Ovarian Cancer Treatment journey.
Reduced through sterile surgical environments and advanced postoperative monitoring.
Common after abdominal surgery and managed with medications.
More likely in elderly or advanced-stage cancer patients.
Includes bowel injury, infection, or fluid buildup after surgery.
Chemotherapy may cause fatigue, nausea, hair loss, and reduced immunity.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Women diagnosed with early or advanced ovarian cancer require surgery, chemotherapy, targeted therapy, or comprehensive cancer care in specialised oncology centres.
Women diagnosed with early or advanced ovarian cancer requiring surgery, chemotherapy, targeted therapy, or comprehensive oncology care in multidisciplinary cancer centres.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Ovarian Cancer Treatment journey.
Treatment depends on cancer stage, spread, and overall health condition.
Budget for surgery, chemotherapy, diagnostics, travel, and accommodation.
Patients may need to stay locally for initial surgery and treatment cycles.
Provide biopsy reports, CT/PET scans, and prior oncology history.
Ensure long-term follow-up with imaging, tumour markers, and oncology consultations.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
